human dopaminergic neurons derived from human embryonic stem cell therapy (Memorial Sloan-Kettering Cancer Center)

N/A

Report date: 2025/01/26 15:33:13

Base Information

Drug Namehuman dopaminergic neurons derived from human embryonic stem cell therapy (Memorial Sloan-Kettering Cancer Center)

Drug Alias NamehESC-derived mDA therapy (Memorial Sloan-Kettering Cancer Center)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMemorial Sloan Kettering Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer Center

Inactive CompaniesN/A

Active IndicationsParkinson Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A